Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Pharmaceutical B2B to IPO

National Business Daily, 1/28/10

Informed sources have revealed that B2B pharmaceutical e-commerce site is planning to IPO on the ChiNext growth enterprise board. According to public information released by the Zhejiang Environmental Protection Bureau, is currently applying for an IPO environmental inspection., based in Hangzhou, was originally a pharmaceutical wholesaler. The company says that funds raised by the listing will be invested in an "e-commerce platform construction and technical upgrade" project. has previously received investment from Sequoia Capital and Sinowisdom. According to internal sources, the company has 10,680 pharmaceutical and medical equipment products from more than 1,000 manufacturers available on its website. The company's 2008 sales volume reached RMB 420 mln, and 2009 revenues are expected to exceed RMB 800 mln.

Keywords: ZC511 Sinowisdom B2B e-commerce Internet IPO Sequoia Capital ChiNext funding revenue


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports